Use of physiological doses of human growth hormone in haematological patients receiving intensive chemotherapy promotes haematopoietic recovery: a double-blind randomized, placebo-controlled study

This publication has 24 references indexed in Scilit:

• Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34+ cells in poor mobilizers
  Blood, 2004
• Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis
  Published by Elsevier ,2004
• A feasibility study of simultaneous administration of gemtuzumab ozogamicin with intensive chemotherapy in induction and consolidation in younger patients with acute myeloid leukemia
  Blood, 2003
• The role of posttransplantation maintenance chemotherapy in improving the outcome of autotransplantation in adult acute lymphoblastic leukemia
  Blood, 2002
• No evidence of tumor growth stimulation in human tumors in vitro following treatment with recombinant human growth hormone
  Anti-Cancer Drugs, 2000
• Increased Mortality Associated with Growth Hormone Treatment in Critically Ill Adults
  New England Journal of Medicine, 1999
• Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth factor binding protein 3 protease
  Critical Care Medicine, 1996
• Bioavailability and bioactivity of intravenous vs subcutaneous infusion of growth hormone in GH‐deficient patients
  Clinical Endocrinology, 1996
• Acquired Growth Hormone Resistance in Patients with Hypercatabolism
  Hormone Research, 1993
• Growth Hormone: Species-Specific Stimulation of Erythropoiesis in Vitro
  Science, 1977